Publications by authors named "Xinyan Xue"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

8

Total Likes

0

Extended Reach

599

Social Features

3
R
Remodeling the hepatic fibrotic microenvironment with emerging nanotherapeutics: a comprehensive review.
Xingtao Zhao, Felix Kwame Amevor, Xinyan Xue, Cheng Wang, Zhifu Cui, Shu Dai, Cheng Peng, Yunxia Li

J Nanobiotechnology· April 2023

Videos about Article: user

1 2

View All Article and Social Media Activity
H
Hydroxylsafflower yellow A modulates tumor vascularization in liver cancer through intercellular communication and extracellular matrix-receptor interactions.
Xinyan Xue, Ke Fu, Mengling Zhou, Yanzhi Li, Shu Dai

Phytomedicine· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxysafflor yellow A exerts anti-fibrotic and anti-angiogenic effects through miR-29a-3p/PDGFRB axis in liver fibrosis.
Xinyan Xue, Yanzhi Li, Shenglin Zhang, Yuxin Yao, Cheng Peng

Phytomedicine· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to 'Carthami flos extract against carbon tetrachloride-induced liver fibrosis via alleviating angiogenesis in mice' Volume 108. [DOI: 10.1016/j.phymed.2022.154517].
Xinyan Xue, Xingtao Zhao, Jing Wang, Cheng Wang, Cheng Ma

Phytomedicine· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Forsythiaside A alleviates acute lung injury by inhibiting inflammation and epithelial barrier damages in lung and colon through PPAR-γ/RXR-α complex.
Jing Wang, Xinyan Xue, Xingtao Zhao, Lin Luo, Juan Liu

J Adv Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comprehensive review of miR-21 in liver disease: Big impact of little things.
Xinyan Xue, Yanzhi Li, Yuxin Yao, Shenglin Zhang, Cheng Peng

Int Immunopharmacol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kaempferol efficacy in metabolic diseases: Molecular mechanisms of action in diabetes mellitus, obesity, non-alcoholic fatty liver disease, steatohepatitis, and atherosclerosis.
Yu-Xin Yao, Yu-Jie Yu, Shu Dai, Chao-Yang Zhang, Xin-Yan Xue

Biomed Pharmacother· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective mechanism of Paeonol on central nervous system.
Rui Wu, Yanfang Liu, Fang Zhang, Shu Dai, Xinyan Xue

Phytother Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Pharmacokinetic Study of Rhubarb Anthraquinones in Normal and Nonalcoholic Fatty Liver Disease Rats.
Fang Zhang, Rui Wu, Yanfang Liu, Shu Dai, Xinyan Xue

Eur J Drug Metab Pharmacokinet· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The protective effect of forsythiaside A on 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced cholestatic liver injury in mice: Based on targeted metabolomics and molecular biology technology.
Ke Fu, Shu Dai, Yanzhi Li, Cheng Ma, Xinyan Xue

Biochim Biophys Acta Mol Basis Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phillygenin Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis: Suppression of Inflammation and Wnt/β-Catenin Signaling Pathway.
Cheng Wang, Yanfang Liu, Lihong Gong, Xinyan Xue, Ke Fu

Inflammation· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
microRNAs-based diagnostic and therapeutic applications in liver fibrosis.
Xingtao Zhao, Xinyan Xue, Zhifu Cui, Felix Kwame Amevor, Yan Wan

Wiley Interdiscip Rev RNA· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Steatosis in metabolic diseases: A focus on lipolysis and lipophagy" [Biomed. Pharmacother. 160 (2023) 114311].
Xingtao Zhao, Felix Kwame Amevor, Zhifu Cui, Yan Wan, Xinyan Xue

Biomed Pharmacother· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Emerging roles of Sirtuins in alleviating alcoholic liver disease: A comprehensive review" [Int. Immunopharmacol. 108 (2022) 108712].
Xingtao Zhao, Xinyan Xue, Cheng Wang, Jing Wang, Cheng Peng

Int Immunopharmacol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective effects of dietary quercetin on cerebral ischemic injury: pharmacology, pharmacokinetics and bioavailability-enhancing nanoformulations.
Yafang Zhang, Ke Fu, Cheng Wang, Cheng Ma, Lihong Gong, Xinyan Xue

Food Funct· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Remodeling the hepatic fibrotic microenvironment with emerging nanotherapeutics: a comprehensive review.
Xingtao Zhao, Felix Kwame Amevor, Xinyan Xue, Cheng Wang, Zhifu Cui

J Nanobiotechnology· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nephroprotective and nephrotoxic effects of Rhubarb and their molecular mechanisms.
Fang Zhang, Rui Wu, Yanfang Liu, Shu Dai, Xinyan Xue

Biomed Pharmacother· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Steatosis in metabolic diseases: A focus on lipolysis and lipophagy.
Xingtao Zhao, Felix Kwame Amevor, Zhifu Cui, Yan Wan, Xinyan Xue

Biomed Pharmacother· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of miR-155 on liver diseases by modulating immunity, inflammation and tumorigenesis.
Xinyan Xue, Jing Wang, Ke Fu, Shu Dai, Rui Wu

Int Immunopharmacol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quercetin alleviates ethanol-induced hepatic steatosis in L02 cells by activating TFEB translocation to compensate for inadequate autophagy.
Xingtao Zhao, Xinyan Xue, Jing Wang, Shu Dai, Cheng Peng

Phytother Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carthami flos extract against carbon tetrachloride-induced liver fibrosis via alleviating angiogenesis in mice.
Xinyan Xue, Xingtao Zhao, Jing Wang, Cheng Wang, Cheng Ma

Phytomedicine· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Response Studies Based on P2X7 Receptors: A Mini-Review.
Ying Deng, Mengting Zhou, Xingtao Zhao, Xinyan Xue, Li Liao

Curr Pharm Des· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging roles of Sirtuins in alleviating alcoholic liver Disease: A comprehensive review.
Xingtao Zhao, Xinyan Xue, Cheng Wang, Jing Wang, Cheng Peng

Int Immunopharmacol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Forsythiae Fructuse extracts alleviates LPS-induced acute lung injury in mice by regulating PPAR-γ/RXR-α in lungs and colons.
Jing Wang, Lin Luo, Xingtao Zhao, Xinyan Xue, Li Liao

J Ethnopharmacol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research Progress of Quercetin Delivery Systems.
Xingtao Zhao, Ying Deng, Xinyan Xue, Li Liao, Mengting Zhou

Curr Pharm Des· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis